Description
As Kalorama Information's lead diagnostic analyst finds, the point of care concept is at a crossroads: the technologies needed to make rapid testing a reality have arrived. But is healthcare ready? ...(more)
Description
REPORT HIGHTLIGHTS
Description
The report provides a detailed understand and analysis of how and why companies enter co-promotion and co-marketing deals. The majority of deals are multicomponent whereby the licensor retains either ...(more)
Description
The driving force behind revenue in biotechnology and pharmaceutical companies is the product. Since the drugs being sold on the market are the most significant assets these companies own and operate...(more)
Description
STUDY OVERVIEW
Today's market driven environment has made performance assessment of managed market account executives complex and critical. Best Practices, LLC has conducted this in-depth stud...(more)
Description
The Manufacturing and Supply Agreements in Pharma, Biotech and Diagnostics, 2nd edition report provides comprehensive understanding and unprecedented access to the manufacturing and supply agreements ...(more)
Description
The Oncology Partnering Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the oncology partnering agreements entered into by the wor...(more)
Description
The Merger and Acquisition Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the merger and acquisition (M&A) agreements entered int...(more)
Description
Introduction
This databook provides insight into the top 10 companies in Canada life sciences industry in terms of their estimated IT spend.
Scope
Description
This report analyzes the worldwide markets for Cardiac Biomarkers in Millions of US$. The market is analyzed by Location-wise (Clinical Laboratory Testing, and Point-of-Care Testing) and by Assay type...(more)
Description
Contraceptives are used for preventing pregnancy and are mainly of two types, hormonal methods and barrier methods, also called as devices. Oral contraceptives account for a major part of the contrace...(more)
Description
Euromonitor International's Eye Care in Germany report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2003-2008), allow...(more)
Description
This report analyzes the worldwide market for Nanocatalysts in US$ Millions. Nanocatalysts find their application in a variety of industry segments. The report broadly classifies and analyzes the glob...(more)
Description
Euromonitor International's Wound Treatments in Germany report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2003-200...(more)
Description
The Chinese Hospital Pharmaceutical Market Outlook to 2014’ provides comprehensive coverage of the Chinese pharmaceutical market, reviewing the market structure, pricing and regulation, and incl...(more)
Description
Euromonitor International's Wound Treatments in Brazil report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2003-2008...(more)
Description
Euromonitor International's Eye Care in Brazil report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2003-2008), allowi...(more)
Description
Germany’s drug market was worth EUR40.6bn in 2008, but is expected to drop slightly to EUR40.1bn in2009. The market is expected to reach EUR43.9bn in 2013, a compound annual growth rate (CAGR) o...(more)
Description
There has been a dramatic increase in the incidence of diabetes worldwide, which has been exacerbated by the growing obesity problem across the globe. Once thought of as primarily a childhood disease-...(more)
Description
Growth in Germany’s drug market is beginning to slow after expanding by 6.45% during 2007, althoughit should remain solid, especially compared with other Western European markets. Between 2008 a...(more)
Description This report comprises defined and up to date development strategies for 409 protein kinase drugs (990 projects) within the portfolio of 160 investigators, from Ceased to Marketed. The report extens...(more)
Description
The Drug Delivery Partnering Agreements in Pharma and Biotech report provides comprehensive understanding and unprecedented access to the drug delivery partnering agreements entered into by the worlds...(more)
Description
The biotechnology and pharmaceutical sectors as we know them will soon cease to exist. Companies in these
sectors have come face-to-face with the harrowing ordeals of a global recession. Four stresses...(more)
Description
Report Description
Home healthcare, also referred to as formal or skilled care, is the support and care service that healthcare professionals provide at the patient’s own home. T...(more)
Description
STUDY OVERVIEW
Charged with building and maintaining physician relationships, pharmaceutical Medical Affairs organizations typically oversee several important functions - including publication...(more)
Description
The multi-billion veterinary health products market, though smaller in opportunity as compared with the human health sector, offers significant return on investment, primarily driven by lower risk and...(more)
© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd 
All rights reserved. Terms and Conditions | Contact us
